Scoop : Sandoz shutters India formulations R&D

Sandoz, the generics arm of Swiss drug maker Novartis AG, has decided to shutter a second research and development (R&D) centre in India in under 12 months.  This time it is the formulations or finished dosage forms R&D unit located in Kalwe, near Mumbai, that is facing closure affecting 147 employees. Continue reading “Scoop : Sandoz shutters India formulations R&D”